Velarion · Company Intelligence
Compensation Brief
Fiscal year 2025 · Filings through 2026-05-21

KORU Medical Systems (KRMD)

Fiscal year 2025 executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.

$2,570,400
Adam Kalbermatten total, FY2025
Chief Commercial Officerhighest-paid officer; CEO Linda Tharby: $1,737,883
CEO (Linda Tharby) pay percentile vs peers
CEO-to-median pay ratio
99.64%
Say-on-pay support, latest vote
Companies that benchmark against KRMD
1 company names KRMD as a compensation peer

Each company listed discloses KRMD in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named KRMD in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.

01

Summary Compensation Table — fiscal year 2025

Named executive officerSalaryBonusStock awardsOption awardsNon-equity incentivePension / NQDCAll otherTotal
Adam Kalbermatten$163,558$0$1,023,000$1,377,300$0$0$6,542$2,570,400
Chief Commercial Officer
Linda Tharby596,9600658,794187,649280,480014,0001,737,883
Chief Executive Officer
Thomas Adams337,8490246,453110,054230,989014,000979,345
Chief Financial Officer

A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.

Three-year trend — total compensation per named executive

Named executive officerFY2025 totalFY2024 totalFY2023 totalΔ FY20242025
Adam Kalbermatten$2,570,400
Linda Tharby1,737,883
Thomas Adams979,345

Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.

02

Equity transactions since the proxy statement was filed

No insider equity transactions reported since the proxy statement.

04

Outstanding equity awards at fiscal year-end 2025

ExecutiveAwardShares unvestedExercise priceMarket value unvested
Linda TharbyPSU580,000$3,369,800
Adam KalbermattenPSU300,0001,743,000
Linda TharbyPSU175,5641,020,027
Linda TharbyPSU167,640973,988
Thomas AdamsPSU65,546380,822
Thomas AdamsPSU37,830219,792
Linda TharbyOption105,7132.35
Adam KalbermattenOption600,0003.44
Linda TharbyOption94,7723.21
Thomas AdamsOption50,0002.54
Thomas AdamsOption35,7922.35
Thomas AdamsOption55,5833.21
05

Incentive-plan design — the Compensation Discussion & Analysis

The Company's goal is to provide an executive compensation program that best serves the long-term interests of its shareholders, using a pay for performance system to drive toward the achievement of increased total shareholder return.

CEO STI target (% of salary)
CEO LTI target (% of salary)
Independent consultantAon Consulting, Inc.
Clawback policytrue
Anti-hedgingtrue
Anti-pledgingtrue
06

Say-on-pay — recent advisory votes

Meeting yearMeeting dateForAgainstAbstainSupportOutcome
20262026-05-1925,723,37991,64943,10699.64%Passed
20252025-05-1423,167,952702,82781,59997.06%Passed
20242024-05-0926,409,104541,923173,89797.99%Passed
20232023-05-1725,941,889113,99827,91699.56%Passed
20222022-05-0628,295,9761,484,846135,21195.01%Passed
20212021-05-1823,151,539241,50497,29398.97%Passed

Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year's compensation.

Say-on-pay — history, company's computation

Meeting yearMeeting dateApproval — company's computation
20262026-05-1999.64%a
20252025-05-1497.06%b
20242024-05-0997.99%c

a. Voting standard not stated in the filing.

b. Voting standard not stated in the filing.

c. Voting standard not stated in the filing.

Approval percentages are the company's own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.

09

Board fee structure and ownership guideline

Annual cash retainer$50,000
Annual equity retainer$60,000
Per board meeting fee
Committee chair fees (audit / comp / nom-gov)15,000 / 11,500 / 7,500
Stock ownership guideline$200,000
10b

Chief executive pay against the peer group

Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.

RankCompanyFYChief executiveSalaryStock awardsOption awardsNon-equity incentiveTotal
1KORU Medical Systems2025Linda Tharby$596,960$658,794$187,649$280,480$1,737,883

Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.

11

Source register

Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.

#SupportsDocumentFiledAccessionLocation in document
1Section 01, Adam KalbermattenDEF 14A2026-04-090001161697-26-000091Section “Executive Compensation”. As printed: 2,570,400. Filing ↗machine: r3 · c9 · span 323782–323791
2Section 01, Linda TharbyDEF 14A2026-04-090001161697-26-000091Section “Executive Compensation”. As printed: 1,737,883. Filing ↗machine: r1 · c9 · span 321426–321435
3Section 01, Thomas AdamsDEF 14A2026-04-090001161697-26-000091Section “Executive Compensation”. As printed: 979,345. Filing ↗
4Section 06, 2026 voteForm 8-K2026-05-210001161697-26-000128Item 5.07 · say-on-pay result. As reported: 99.64% (votes for as printed: 25,723,379). Filing ↗
5Section 06, 2025 voteForm 8-K2025-05-150001161697-25-000173Item 5.07 · say-on-pay result. As reported: 97.06% (votes for as printed: 23,167,952). Filing ↗
6Section 06, 2024 voteForm 8-K2024-05-140001161697-24-000230Item 5.07 · say-on-pay result. As reported: 97.99% (votes for as printed: 26,409,104). Filing ↗
7KORU Medical Systems (subject), Section 10b CEO totalDEF 14A2026-04-090001161697-26-000091CEO total compensation as printed in KORU Medical Systems's own proxy. As printed: 1,737,883. Filing ↗machine: r1 · c9 · span 321426–321435